Dr. Singhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Department Of Neurology, Bwh
Boston, MA 02115Phone+1 617-732-5500Fax+1 203-688-5599
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2009 - 2012
- Yale-New Haven Medical CenterInternship, Internal Medicine, 2008 - 2009
- All India Institute of Medical SciencesClass of 2002
Certifications & Licensure
- OH State Medical License Current
- MA State Medical License 2011 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease Start of enrollment: 2016 May 02
- Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA Start of enrollment: 2017 Mar 24
- Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis Start of enrollment: 2019 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 61 citationsLong-term study of port-site incisional hernia after laparoscopic procedures.Abdulzahra Hussain, Hind Mahmood, Tarun Singhal, Santosh Balakrishnan, J. Nicholls
JSLS. 2009-03-06 - 92 citations11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRITarun Singhal, Tanjore K. Narayanan, Martin P. Jacobs, Chandrashekhar Bal, Joseph Mantil
Journal of Nuclear Medicine. 2012-11-01 - 7 citationsThird generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.K Prasad, T Singhal, N Jain, P K Gupta
The Cochrane Database of Systematic Reviews. 2004-01-01
Press Mentions
- Tiziana Announces Positive Clinical Data from a Secondary Progressive Multiple Sclerosis Patient Treated for Six Months with Intranasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal AntibodyMarch 10th, 2022
- Researchers Pursue 'Hidden Pathology' to Explain Fatigue in Multiple SclerosisAugust 26th, 2020
- PET Tracer Can Help ID Early Signs of MS ProgressionJuly 10th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: